Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Dexamethasone + NMS-03597812 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Dexamethasone | Adexone | Desametasone | ||
| NMS-03597812 | NMS 03597812|NMS03597812 | NMS-03597812 inhibits PERK, potentially leading to apoptosis of tumor cells and decreased tumor growth (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05027594 | Phase I | Dexamethasone + NMS-03597812 NMS-03597812 | Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma | Terminated | USA | 0 |